Reminder: CytoDyn to Hold Investment Community Conference Call April 18, 2017

Download PDF

VANCOUVER, Washington, April 13, 2017 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, will hold an investment community conference call to provide an update on clinical trial and regulatory developments.

Date:     Tuesday, April 18, 2017
Time:      1:00 p.m. PT / 4:00 p.m. ET 
U.S./Canada Dial In:     877-407-2986 
International Dial In:     201-378-4916

A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days.  Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software.  The webcast can also be accessed via the following link: http://cytodyn.equisolvewebcast.com/4-18-17.

A replay of the conference call will be available until June 18, 2017.  To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13652328.

CONTACTS:
Investors:
LHA
Jody Cain
Office: 310-691-7100
E-mail: jcain@lhai.com

Media:
Nader Pourhassan, Ph.D.
President & CEO
Office: 360-980-8524
Email: npourhassan@cytodyn.com

Primary Logo

Source: CytoDyn Inc.